Immune checkpoint inhibitor-induced myocarditis and myositis in liver cancer patients: A case report and literature review

With the development of immunotherapy, immune checkpoint inhibitors (ICIs) are widely used in clinical oncology and have achieved good results. ICIs could induce immune-related adverse events (irAEs) in cancer treatment, which warrant sufficient attention. Among them, immune myositis can manifest se...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Haoran, Wen, Wu, Fang, Kang, Xiong, Yuanpeng, Liu, Weiqi, Wang, Jie, Wan, Renhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876740/
https://www.ncbi.nlm.nih.gov/pubmed/36713559
http://dx.doi.org/10.3389/fonc.2022.1088659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876740/
https://www.ncbi.nlm.nih.gov/pubmed/36713559
http://dx.doi.org/10.3389/fonc.2022.1088659

Ejemplares similares